Determination of meloxicam in human plasma by liquid chromatography-tandem mass spectrometry following transdermal administration

被引:35
作者
Yuan, Yue
Chen, Xiaoyan
Zhong, Dafang
机构
[1] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China
[2] Shenyang Pharmaceut Univ, Sch Pharm, Shenyang 110016, Peoples R China
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2007年 / 852卷 / 1-2期
关键词
meloxicam; LC-MS-MS; pharmacokinetics; transdermal;
D O I
10.1016/j.jchromb.2007.01.036
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A highly sensitive and selective liquid chromatography-tandem mass spectrometry (LC-MS-MS) method was developed to determine meloxicam of low concentration in human plasma. After a simple sample preparation procedure by one-step protein precipitation with methanol, meloxicam and the internal standard piroxicam were chromatographed on a Zorbax SB C-18 column. The mobile phase consisted of acetonitrile-water-formic acid (80:20:0.2, v/v/v). Detection was performed on a triple quadrupole tandem mass spectrometer by selected reaction monitoring (SRM) mode via eletrospray ionization (ESI) source. The method had a lower limit of quantification of 0.10 ng/ml. The calibration curve was demonstrated to be linear over the concentration range of 0.10-50.0 ng/ml. The assay was specific, accurate (percentage deviations from nominal concentrations were within 2.5%), precise (intra- and inter-day relative standard deviation (R.S.D.) < 7%). The validated method was successfully applied to the determination of meloxicam in human plasma collected up to 180 h after a transdermal administration of 30 mg meloxicam for evaluation of the pharmacokinetics. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:650 / 654
页数:5
相关论文
共 8 条
[1]  
BEVIS PJ, 1996, BR J RHEUMATOL, V35, P44
[2]   LC determination and pharmacokinetics of meloxicam [J].
Dasandi, B ;
Shivaprakash ;
Saroj, H ;
Bhat, KM .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2002, 28 (05) :999-1004
[3]   Clinical pharmacokinetics of meloxicam - A cyclo-oxygenase-2 preferential nonsteroidal anti-inflammatory drug [J].
Davies, NM ;
Skjodt, NM .
CLINICAL PHARMACOKINETICS, 1999, 36 (02) :115-126
[4]   Comparison of analgesic and anti-inflammatory activity of meloxicam gel with diclofenac and piroxicam gels in animal models: Pharmacokinetic parameters after topical application [J].
Gupta, SK ;
Bansal, P ;
Bhardwaj, RK ;
Jaiswal, J ;
Velpandian, T .
SKIN PHARMACOLOGY AND APPLIED SKIN PHYSIOLOGY, 2002, 15 (02) :105-111
[5]   Simultaneous determination of piroxicam, meloxicam and tenoxicam in human plasma by liquid chromatography with tandem mass spectrometry [J].
Ji, HY ;
Lee, HW ;
Kim, YH ;
Jeong, DW ;
Lee, HS .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2005, 826 (1-2) :214-219
[6]   SENSITIVE METHOD FOR THE DETERMINATION OF DICLOFENAC IN HUMAN-PLASMA BY GAS-CHROMATOGRAPHY MASS-SPECTROMETRY [J].
KADOWAKI, H ;
SHIINO, M ;
UEMURA, I ;
KOBAYASHI, K .
JOURNAL OF CHROMATOGRAPHY, 1984, 308 (JUN) :329-333
[7]   Sensitive and rapid liquid chromatography-tandem mass spectrometry method for the determination of meloxicam in human plasma [J].
Wiesner, JL ;
de Jager, AD ;
Sutherland, FCW ;
Hundt, HKL ;
Swart, KJ ;
Hundt, AF ;
Els, J .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2003, 785 (01) :115-121
[8]  
Xu Hai-yan, 2001, Yaoxue Xuebao, V36, P71